Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of EULAR-RAID score in rheumatoid arthritis patients treated with etanercept
2007-007888-24Phase 4Completed
- Sponsor
- Wyeth
- Start
- Jul 2008
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etanercept in rheumatoid arthritis (RA), sponsored by Wyeth. Primary endpoint: Psychometric properties of EULAR-RAID score. Started Jul 2008; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-007888-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007888-24.